Synthesis and Inhibiting Activity of Some 4-Hydroxycoumarin Derivatives on HIV-1 Protease

Author:

Stanchev Stancho1,Jensen Frank2,Hinkov Anton3,Atanasov Vasil4,Genova-Kalou Petia5,Argirova Radka6,Manolov Ilia7

Affiliation:

1. Department of Chemistry, Faculty of Pharmacy, 2 Dunav Street, 1000 Sofia, Bulgaria

2. Department of Chemistry, Faculty of Science, University of Aarhus, Langelandsgade 140, 8000 Aarhus C, Denmark

3. Laboratory of Virology, Faculty of Biology, Sofia University “St. Kliment Ohridski”, 8 Dragan Zankov, 1164 Sofia, Bulgaria

4. Laboratory of Biocoordination and Bioanalytical Chemistry, Faculty of Chemistry, Sofia University “St. Kliment Ohridski”, 1 J. Bourchier, 1164 Sofia, Bulgaria

5. Laboratory of Cell Cultures, National Center of Infectious and Parasitic Diseases, 44 A Stoletov Street, 1233 Sofia, Bulgaria

6. Laboratory of Retroviruses, National Center of Infectious and Parasitic Diseases, 44 A Stoletov Street, 1233 Sofia, Bulgaria

7. Department of Pharmaceutical Chemistry, Faculty of Pharmacy, 2 Dunav Street, 1000 Sofia, Bulgaria

Abstract

Six novel 4-hydroxycoumarin derivatives were rationally synthesized, verified, and characterized by molecular docking using crystal HIV-1 protease. Molecular docking studies predicted antiprotease activity of (7) and (10). The most significant functional groups, responsible for the interaction with HIV-1 protease by hydrogen bonds formation are pyran oxygen, atom, lactone carbonyl oxygen and one of the hydroxyl groups. The newly synthesized compounds were biologically tested in MT-4 cells for inhibiting HIV-1 replication, exploring the protection of cells from the cytopathic effect of HIV measured by cell survival in MTT test. One derivative −7 showed 76–78% inhibition of virus infectivity with IC50 = 0.01 nM, much less than the maximal nontoxic concentration (1 mM). Antiprotease activity of 7 in two different concentrations was detected to be 25%. Nevertheless, the results of study of (7) encourage using it as a pharmacophore for further synthesis and evaluation of anti-HIV activity.

Publisher

Hindawi Limited

Subject

Pharmacology (medical)

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3